Early intervention in knee osteoarthritis with genicular artery embolization is associated with improved clinical outcomes - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Timely Genicular Artery Embolization for Knee Osteoarthritis Linked to Enhanced Clinical Outcomes

  • By

  • Tyler Callese

  • Lucas R. Cusumano

  • Hiro Sparks

  • Kara Masterson

  • Scott Genshaft

  • Jessica K. Stewart

  • Siddharth A. Padia

  • May 29, 2025

Share

Clinical Scorecard: Timely Genicular Artery Embolization for Knee Osteoarthritis Linked to Enhanced Clinical Outcomes

At a Glance

CategoryDetail
ConditionKnee osteoarthritis (OA)
Key MechanismsMinimally invasive genicular artery embolization (GAE) targeting abnormal synovial hyperemia to reduce pain
Target PopulationPatients with symptomatic moderate to severe knee OA (KL grade 2–4) who failed conservative management and are ineligible for or refuse total knee arthroplasty (TKA)
Care SettingOutpatient ambulatory setting under moderate sedation at tertiary care centers

Key Highlights

  • GAE is a minimally invasive outpatient procedure with minimal risks and potential to bridge conservative therapies and TKA.
  • Success rates of GAE range from 60% to 86%, with patient selection factors influencing outcomes.
  • One-year follow-up is critical to assess durability and avoid short-term placebo effects.

Guideline-Based Recommendations

Diagnosis

  • Confirm moderate to severe knee pain ≥5/10 on visual analog scale.
  • Radiographic confirmation of knee OA with Kellgren–Lawrence grade 2–4.
  • Assess failure of conservative management including physical therapy, medications, and intra-articular injections.

Management

  • Perform GAE in patients who are not candidates for or refuse TKA after failed conservative treatment.
  • Use radiopaque skin markers to localize pain sites pre-procedure.
  • Conduct digital subtraction angiography and cone-beam CT to identify target genicular arteries.
  • Embolize abnormal hyperemic vessels with 100-mm particles preserving normal arterial flow.
  • Discharge patients approximately 4 hours post-procedure.

Monitoring & Follow-up

  • Follow-up for at least one year to evaluate clinical success and durability of symptom relief.
  • Monitor for complications related to embolization and vascular access.

Risks

  • Potential risks are minimal but include contrast allergy and impaired renal function which are contraindications.
  • Procedural risks related to arterial access and embolization must be considered.

Patient & Prescribing Data

Patients with symptomatic moderate to severe knee OA, KL grade 2–4, who failed conservative therapies and are not candidates for or refuse TKA.

GAE offers a safe, minimally invasive option with success rates between 60% and 86%, providing symptom relief and potentially delaying or avoiding TKA.

Clinical Best Practices

  • Careful patient selection based on pain severity, radiographic grading, and failure of conservative management.
  • Use intra-procedural imaging including DSA and cone-beam CT to precisely target embolization.
  • Preserve normal arterial flow while embolizing abnormal hyperemic vessels to minimize complications.
  • Prefer ipsilateral antegrade femoral artery access for better catheter control.
  • Ensure at least one year of follow-up to assess long-term outcomes.

References

Original Source(s)

Related Content